Glucagon treatment interferes with an early step of duck hepatitis B virus infection.

Hild, M; Weber, O; Schaller, H

Hild, M; Weber, O; Schaller, H.

Affiliation

Hild M; Zentrum für Molekulare Biologie (ZMBH), Universität Heidelberg, Germany.

J Virol ; 72(4): 2600-6, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9525576

Subject(s)

Antiviral Agents/pharmacology; Glucagon/pharmacology; Hepadnaviridae Infections/prevention & control; Hepatitis B Virus, Duck/drug effects; Animals; Bucladesine/pharmacology; Cells, Cultured; Colforsin/pharmacology; Cyclic AMP/metabolism; DNA, Circular/biosynthesis; Disease Susceptibility; Ducks; Gene Amplification; Hepatitis B Virus, Duck/genetics; Hepatitis B Virus, Duck/physiology; Intracellular Fluid; Time Factors; Virus Replication/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Glucagon / Hepatitis B Virus, Duck / Hepadnaviridae Infections Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Virol Year: 1998 Document type: Article Affiliation country: Germany Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google